Cargando…

Molecular determinants of orexin receptor-arrestinubiquitin complex formation

Background and Purpose: The orexin system regulates a multitude of key physiological processes, particularly involving maintenance of metabolic homeostasis. Consequently, there is considerable potential for pharmaceutical development for the treatment of disorders from narcolepsy to metabolic syndro...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaeger, Werner C, Seeber, Ruth M, Eidne, Karin A, Pfleger, Kevin DG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3904257/
https://www.ncbi.nlm.nih.gov/pubmed/24206104
http://dx.doi.org/10.1111/bph.12481
_version_ 1782301202846842880
author Jaeger, Werner C
Seeber, Ruth M
Eidne, Karin A
Pfleger, Kevin DG
author_facet Jaeger, Werner C
Seeber, Ruth M
Eidne, Karin A
Pfleger, Kevin DG
author_sort Jaeger, Werner C
collection PubMed
description Background and Purpose: The orexin system regulates a multitude of key physiological processes, particularly involving maintenance of metabolic homeostasis. Consequently, there is considerable potential for pharmaceutical development for the treatment of disorders from narcolepsy to metabolic syndrome. It acts through the hormonal activity of two endogenous peptides, orexin A binding to orexin receptors 1 and 2 (OX(1) and OX(2)) with similar affinity, and orexin B binding to OX(2) with higher affinity than OX(1) receptors. We have previously revealed data differentiating orexin receptor subtypes with respect to their relative stability in forming orexin receptor-arrestin-ubiquitin complexes measured by BRET. Recycling and cellular signalling distinctions were also observed. Here, we have investigated, using BRET, the molecular determinants involved in providing OX(2) receptors with greater β-arrestin-ubiquitin complex stability. Experimental Approach: The contribution of the C-terminal tail of the OX receptors was investigated by bulk substitution and site-specific mutagenesis using BRET and inositol phosphate assays. Key Results: Replacement of the OX(1) receptor C-terminus with that of the OX(2) receptor did not result in the expected gain of function, indicating a role for intracellular domain configuration in addition to primary structure. Furthermore, two out of the three putative serine/threonine clusters in the C-terminus were found to be involved in OX(2) receptor-β-arrestin-ubiquitin complex formation. Conclusions and Implications: This study provides fundamental insights into the molecular elements that influence receptor-arrestin-ubiquitin complex formation. Understanding how and why the orexin receptors can be functionally differentiated brings us closer to exploiting these receptors as drug targets. Linked Articles: This article is part of a themed section on Orexin Receptors. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2014.171.issue-2
format Online
Article
Text
id pubmed-3904257
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher John Wiley & Sons Ltd
record_format MEDLINE/PubMed
spelling pubmed-39042572014-12-08 Molecular determinants of orexin receptor-arrestinubiquitin complex formation Jaeger, Werner C Seeber, Ruth M Eidne, Karin A Pfleger, Kevin DG Br J Pharmacol Themed Section: Orexin Receptors Background and Purpose: The orexin system regulates a multitude of key physiological processes, particularly involving maintenance of metabolic homeostasis. Consequently, there is considerable potential for pharmaceutical development for the treatment of disorders from narcolepsy to metabolic syndrome. It acts through the hormonal activity of two endogenous peptides, orexin A binding to orexin receptors 1 and 2 (OX(1) and OX(2)) with similar affinity, and orexin B binding to OX(2) with higher affinity than OX(1) receptors. We have previously revealed data differentiating orexin receptor subtypes with respect to their relative stability in forming orexin receptor-arrestin-ubiquitin complexes measured by BRET. Recycling and cellular signalling distinctions were also observed. Here, we have investigated, using BRET, the molecular determinants involved in providing OX(2) receptors with greater β-arrestin-ubiquitin complex stability. Experimental Approach: The contribution of the C-terminal tail of the OX receptors was investigated by bulk substitution and site-specific mutagenesis using BRET and inositol phosphate assays. Key Results: Replacement of the OX(1) receptor C-terminus with that of the OX(2) receptor did not result in the expected gain of function, indicating a role for intracellular domain configuration in addition to primary structure. Furthermore, two out of the three putative serine/threonine clusters in the C-terminus were found to be involved in OX(2) receptor-β-arrestin-ubiquitin complex formation. Conclusions and Implications: This study provides fundamental insights into the molecular elements that influence receptor-arrestin-ubiquitin complex formation. Understanding how and why the orexin receptors can be functionally differentiated brings us closer to exploiting these receptors as drug targets. Linked Articles: This article is part of a themed section on Orexin Receptors. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2014.171.issue-2 John Wiley & Sons Ltd 2014-01 2013-12-23 /pmc/articles/PMC3904257/ /pubmed/24206104 http://dx.doi.org/10.1111/bph.12481 Text en Copyright © 2014 The British Pharmacological Society http://creativecommons.org/licenses/by/2.5/ Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.
spellingShingle Themed Section: Orexin Receptors
Jaeger, Werner C
Seeber, Ruth M
Eidne, Karin A
Pfleger, Kevin DG
Molecular determinants of orexin receptor-arrestinubiquitin complex formation
title Molecular determinants of orexin receptor-arrestinubiquitin complex formation
title_full Molecular determinants of orexin receptor-arrestinubiquitin complex formation
title_fullStr Molecular determinants of orexin receptor-arrestinubiquitin complex formation
title_full_unstemmed Molecular determinants of orexin receptor-arrestinubiquitin complex formation
title_short Molecular determinants of orexin receptor-arrestinubiquitin complex formation
title_sort molecular determinants of orexin receptor-arrestinubiquitin complex formation
topic Themed Section: Orexin Receptors
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3904257/
https://www.ncbi.nlm.nih.gov/pubmed/24206104
http://dx.doi.org/10.1111/bph.12481
work_keys_str_mv AT jaegerwernerc moleculardeterminantsoforexinreceptorarrestinubiquitincomplexformation
AT seeberruthm moleculardeterminantsoforexinreceptorarrestinubiquitincomplexformation
AT eidnekarina moleculardeterminantsoforexinreceptorarrestinubiquitincomplexformation
AT pflegerkevindg moleculardeterminantsoforexinreceptorarrestinubiquitincomplexformation